Kaempferol is an estrogen-related receptor α and γ inverse agonist  by Wang, Junjian et al.
FEBS Letters 583 (2009) 643–647journal homepage: www.FEBSLetters .orgKaempferol is an estrogen-related receptor a and c inverse agonist
Junjian Wang, Fang Fang, Zhiyan Huang, Yanfei Wang, Chiwai Wong *
Center of Integrative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510663, Chinaa r t i c l e i n f o
Article history:
Received 17 November 2008
Revised 13 January 2009
Accepted 17 January 2009
Available online 24 January 2009
Edited by Robert Barouki
Keywords:
Estrogen receptor
Estrogen-related receptor
Kaempferol0014-5793/$34.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.01.030
Abbreviations: ERR, estrogen-related receptor; ER
peroxisome proliferator-activated receptor c coactiv
domains; 4-OHT, 4-hydroxytamoxifene; RU, resonanc
resonance; PDK, pyruvate dehydrogenase kinase
* Corresponding author. Fax: +86 20 32290606.
E-mail address: wong_chiwai@gibh.ac.cn (C. Wonga b s t r a c t
Kaempferol is a dietary ﬂavonoid that is thought to function as a selective estrogen receptormodula-
tor. In this study, we established that kaempferol also functions as an inverse agonist for estrogen-
related receptors alpha and gamma (ERRa and ERRc). We demonstrated that kaempferol binds to
ERRa and ERRc and blocks their interaction with coactivator peroxisome proliferator-activated
receptor c coactivator-1a (PGC-1a). Kaempferol also suppressed the expressions of ERR-target genes
pyruvatedehydrogenasekinase 2and4 (PDK2andPDK4). This evidence suggests that kaempferolmay
exert some of its biological effect through both estrogen receptors and estrogen-related receptors.
Structured summary:
MINT-6824653: PGC-1 alpha (uniprotkb:Q9UBK2) and ERR gamma (uniprotkb: P62508) bind (MI:0407) by
surface plasmon resonance (MI:0107)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Phytoestrogens are polyphenolic non-steroidal plant com-
pounds that function at least in part as selective estrogen recep-
tor modulators (SERMs) to inﬂuence the transcriptional response
to estrogens in both context dependent and tissue selective man-
ners [1,2]. Kaempferol (3,40,5,7-tetrahydroxyﬂavone) is one of the
most commonly found dietary ﬂavonoid and has been isolated
from tea, broccoli, grapefruit, and other plant sources [3].
Kaempferol has been suggested to play a role in preventing post-
menopausal conditions, namely cardiovascular disease, hot
ﬂushes and osteoporosis [4]. Kaempferol can also induce growth
arrest and apoptosis in colorectal, lung and prostate cancers
through inhibiting DNA synthesis, inducing nuclear DNA degrada-
tion, and inhibiting kinase activities albeit at non-physiological
concentrations [5–7].
Estrogen-related receptors alpha, beta and gamma (ERRa,
ERRb, and ERRc) are members of the nuclear hormone receptor
superfamily that were identiﬁed on the basis of their high levels
of sequence identity to estrogen receptors (ERs) [8]. Like other
nuclear hormone receptors, ERRs and ERs are comprised of N-ter-chemical Societies. Published by E
, estrogen receptor; PGC-1a,
ator-1a; LBD, ligand binding
e units; SPR, surface plasmon
).minal transcriptional activating domains (AF-1), centrally located
DNA binding domains (DBD), variable hinge regions, and C-termi-
nally located ligand binding domains (LBD) that harbor the li-
gand-dependent transcriptional activating function (AF-2) [9].
The LBDs of ERRs differ to that of ERs in primary sequences and
that ERRs do not bind to estrogen 17b-estradiol; nonetheless,
they share some common characteristics and abilities to bind to
SERMs. Speciﬁcally, ER antagonist 4-hydroxytamoxifene (4-OHT)
has also been shown to be an antagonist for both ERRb and ERRc
[10,11]. Recent studies have also collectively suggested that nat-
ural or synthetic selective ligands for ERRa, ERRb and ERRc exist
[12,13]. In this study, we explored if kaempferol would also exert
some of its biological effects by modulating the activities of ERRs,
employing a reporter-based activity screening system, a receptor-
coactivator interacting assay and marker gene expression analy-
sis, we identiﬁed kaempferol as an ERRa and ERRc inverse
agonist.2. Materials and methods
2.1. Cell culture and reagents
HeLa and HepG2 cells were cultured according to ATCC instruc-
tion. Kaempferol was purchased from Shannxi Huike Botanical
Development Co., Ltd. The BIAcore 3000 system, certiﬁed SA sensor
chips, amine coupling reagents (EDC, NHS, and ethanolamine HCl),
HBS and 0.5% SDS were obtained from BIAcore Inc.lsevier B.V. All rights reserved.
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Expression vectors containing human cDNA of pCMX-hERRa,
pCMX-hERRc and pcDNA4-hPGC-1a were kindly provided by Dr.
Hongwu Chen and Dr. Brian Lavan. PDK4-promoter was ampliﬁed
and subcloned into pGL3 plasmid from HepG2 genomic DNA
by primers 50-TTGGAGTAAGGACATTTCGTACAGG-30 and
50-GCTCAGCAGCAAAGTGAACCC-30 [14]. Expression vectors in
pCMV-Gal4DBD and pET-30 a (+) were generated by subcloning
the LBDs (ERRa: amino acids 144–423; ERRc: amino acids 168–
350) of the corresponding nuclear hormone receptors into the
appropriate vectors. All plasmids were sequence veriﬁed.
2.3. Transient transfection and luciferase assays
Cells were plated at a density of 10000 cells/well (96-well
plates) in phenol red free DMEMmedium (Hyclone) supplemented
with 10% (v/v) charcoal stripped fetal bovine serum. Cells were
transiently transfected with Lipofectamine 2000 (Invitrogen, Carls-
bad, CA). Cells were transfected with 20 ng per well expression
plasmids of either Gal4-DBD-ERa-LBD, -ERb-LBD, ERRa-LBD, or
-ERRc-LBD together with 20 ng per well luciferase reporter UAS-
Luc and 5 ng per well control Renilla luciferase plasmid. For ERRa
and ERRc assays 10 ng per well pcDNA-PGC-1a expression vector
was also added. Alternatively, HepG2 cells were cotransfected with
20 ng per well pGL3-PDK4-promoter-Luc and 20 ng per well
pCMX-hERRa or pCMX-hERRc, with or without 10 ng per well
pcDNA-PGC-1a, and 5 ng per well Renilla luciferase plasmid. After
cells were transfected for 6 h, compounds were then added for an
additional 24 h. Luciferase activity was measured by Dual-Lucifer-
ase Reporter Assay System (Promega).0
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Fig. 1. Effects of kaempferol on the activities of ERs and ERRs. (A and B) HeLa cells we
together with luciferase reporter and control Renilla luciferase plasmid. Kaempferol or 1
induction indicates the activities of ERs under the inﬂuence of kaempferol compared to D
of Gal4-DBD-ERRa-LBD or ERRc-LBD and pcDNA-PGC-1a together with reporter UAS-
(10 lM), or 4-OHT (1 lM) was added and enzyme assays were performed as in (A); % Ac
compared to DMSO control set at 100%. Results represent mean ± S.D. **P 6 0.01.2.4. Interactions between coactivator and ERR-LBDs analyzed by
BIAcore 3000
Interactions between hERRc-LBD and PGC-1a coactivator pep-
tides in the presence of kaempferol were analyzed using a BIAcore
3000 system. Human ERRc LBD protein was expressed in Esche-
richia coli BL21(DE3) with 0.5 mM IPTG induction at 15 C for
20 h and puriﬁed to more than 95% pure by a Ni-NTA column (QIA-
gene). Biotinylated PGC-1a NR2 EEPSLLKKLLLAPAN and negative
NR2 EEPSLAKKAALAPAN peptides were captured onto streptavidin
immobilized surface of a SA chip. After stabilization of surface by
injection of 0.05% SDS, 30 nM of hERRc-LBD incubated with vari-
ous ligands in running buffer (50 mM Tris pH 8.0, 150 mM NaCl,
1 mM MgCl2, 0.002% NP-40, 0.2 mM DTT) were injected into ﬂow
cells for 3 min at a ﬂow rate of 20 lL/min at 25 C. Changes in res-
onance units (RU) were monitored simultaneously in all ﬂow cells.
Surface was regenerated at the end of each cycle by a quick injec-
tion of 0.05% SDS. Sensorgrams were generated by BIAcontrol soft-
ware 4.1 using double-referencing to eliminate responses from the
reference surface and buffer-only control. Speciﬁc changes in RU
were generated with non-speciﬁc interaction between LBD and
NR2 negative control mutant peptide deducted.2.5. Real-time PCR analysis
Total cDNA was used in a real-time PCR kit (Takara, Dalian, Chi-
na) and the mRNA levels were detected by SYBR green ﬂuorescence
on ABI7300 machine. 18S rRNA was used as an internal control.
Fold repression was calculated by 2DDCt. Primers and conditions
will be provided upon request.0
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Fig. 2. Kaempferol directly binds to ERR-LBDs and blocks coactivator interaction.
(A) Puriﬁed ERRc-LBD was tested for its interaction with PGC-1a LXXLL motif as
described in materials and methods. (B) DMSO, 10 lM DY-131, or 1 lM 4-OHT was
incubated with 30 nM puriﬁed ERRc-LBD before analysis as in (A). (C) Different
doses of kaempferol were tested as in (B).
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3.1. Kaempferol is an estrogen receptor agonist and estrogen-related
receptor inverse agonist
We ﬁrst investigated if kaempferol displayed agonistic or antag-
onistic activities on both ERs and ERRs in HeLa cells. HeLa were
then tranfected with a luciferase reporter under the control of
Gal4-DBD fusions, Gal4-DBD-ER or ERR-LBD expression vectors,
and a Renilla luciferase vector as an internal control. Compared to
17b-estradiol as a positive control, we found that kaempferol en-
hanced the activities of both ERa and ERb while showing a strong
preference for ERb over ERa (Fig. 1A and B), conﬁrming kaempferol
as a selective estrogen receptor modulator.
While the activities of estrogen receptors are stimulated by ago-
nists, ERRs are constitutively active receptors that display strong
transcriptional activities particularly in conjunctionwith their coac-
tivator peroxisome proliferator-activated receptor c coactivator-1a
(PGC-1a) [15]. We then asked if kaempferol would affect the activ-
ities of ERRa and ERRc with cotransfection of a PGC-1a expression
plasmid. Compared to two well established inverse agonists XCT-
790 and 4-OHT of ERRa and ERRc respectively [10,11,16], we found
that kaempferol strongly suppressed ERRa and ERRc activities in a
dose dependent manner (Fig. 1C and D), strongly indicating that
kaempferol acted as an inverse agonist of both ERRa and ERRc.
3.2. Kaempferol binds to ERR-LBDs and blocks their interaction with
coactivator
Although kaempferol functions as an inverse agonist in the cell
based assay system, it remains to be established that kaempferol
would bind directly to the LBDs of ERRs. We then employed an
in vitro puriﬁed protein system to conﬁrm if kaempferol can di-
rectly bind to the LBD of ERRc. ERRc-LBD was expressed as a
His-tagged fusion protein in bacteria and puriﬁed over a Ni-NTA
column to appropriately 95% in purity (data not shown). We then
analyzed the interaction between the puriﬁed ERRc-LBD and the
LXXLL motif (nuclear receptor interacting box) of coactivator
PGC-1a by a biophysical method. The puriﬁed ERRc LBD was incu-
bated with DMSO as a vehicle, an ERRc synthetic agonist DY-131
[12], the ERRc inverse agonist 4-OHT, or different doses of kaempf-
erol. These ligand-bound LBDs were then allowed to pass through a
sensor chip on which the LXXLL motif or control mutant peptides
of coactivator PGC-1a were immobilized [17]. The speciﬁc interac-
tions between the coactivator LXXLL peptides with that of LBDs
were monitored by measuring the changes in surface plasmon res-
onance (SPR) with the non-speciﬁc interaction between the LBDs
and mutant peptides deducted.
We ﬁrst established that ERRc-LBD constitutively bound to PGC-
1a LXXLL motif in a dose dependent manner (Fig. 2A). This consti-
tutive interaction was enhanced by ERRc agonist DY-131 but was
reduced by ERRc inverse agonist 4-OHT (Fig. 2B). We found that
kaempferol reduced the interaction between ERRc-LBD and PGC-
1a LXXLL motif in a dose dependent manner (Fig. 2C). In addition,
we also found that kaempferol reduced the interaction between
ERRa-LBD and PGC-1a by this method (data not shown). Since this
system used puriﬁed LBDs, it is therefore likely that kaempferol di-
rectly bound to ERRs and suppressed their interaction with coacti-
vators thus functioning as an inverse agonist.
3.3. Kaempferol decreases the expressions of ERR-regulated target
genes
While we established that kaempferol was able to function as
an inverse agonist of ERRa and ERRc through their respective LBDs,whether kaempferol would affect the expression levels of ERR-tar-
get genes remain to be investigated. Pyruvate dehydrogenase ki-
nase 2 and 4 (PDK2 and PDK4) are ERRa and ERRc target genes
[14,18]. We ﬁrst cloned the 2 kb upstream promoter of PDK4 con-
taining ERR response elements into a luciferase reporter vector
pGL3. Cotransfection of HepG2 cells with this reporter together
with expression vectors of ERRa or ERRc and coactivator PGC-1a
stimulated the expression of this reporter (Fig. 3A and B). We
found that kaempferol dose dependently suppressed the induc-
tions of PDK promoter by both ERRa and ERRc and the coactivation
mediated by PGC-1a (Fig. 3A and B). Importantly, we found that
kaempferol suppressed the expression levels of endogenous
PDK2 and PDK4 mRNA measured by quantitative real-time PCR
(Fig. 3C). Collectively, these results suggested that kaempferol
functioned to suppress the activities of ERRs.4. Discussion
As an ERb selective agonist at sub-micromolar concentrations,
the physiological function of kaempferol has been attribute to it
being a selective estrogen receptor modulator [1,2]. In addition,
kaempferol has been studied as an antagonist of aryl hydrocarbon
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Fig. 3. Effects of Kaempferol on the ERRs target gene expression. (A and B) HepG2
cells were cotransfected with pGL3-PDK4 promoter-Luc, expression vectors for
ERRa or hERRc, with or without an expression vector for PGC-1a, and Renilla
luciferase plasmid. Kaempferol (0, 5, 10, 20 lM) addition and enzyme assays were
performed as in Fig. 1. Fold induction indicates the activities of PDK4-promoter
under the inﬂuence of ERRs and PGC-1a compared to empty expression vector
control set at one. Results represent mean ± S.D. *P 6 0.05, **P 6 0.01. (C) HepG2
cells were treated with kaempferol at 10 lM for 24 h before RNA collection. The
expression levels of ERR-target genes PDK2 and PDK4 were measured by real time
PCR with 18S rRNA used as a control. The relative expression level of gene with
DMSO as control was set at one.
646 J. Wang et al. / FEBS Letters 583 (2009) 643–647receptor (AhR) [19]. Using a cell based Gal4-DBD-ERR-LBD screen-
ing assay, an in vitro puriﬁed LBD-coactivator interaction assay,
and target gene expression analysis; we established that kaempfer-
ol functioned as an inverse agonist of both ERRa and ERRc. There-
fore, depending on the cellular concentrations, kaempferol can
modulate the activities of some or all of these receptors.
It appears that the level of suppression may be modiﬁed by the
ligand independent transcriptional activities (AF-1) located at the
N-terminal regions of ERRs. Kaempferol suppresses the activities
of both ERRa-LBD and ERRc-LBD to similar extents in the Gal4-
DBD assays (Fig. 1C and D). However, kaempferol suppresses the
full length ERRa-mediated induction of PDK4 expression more
avidly than ERRc (Fig. 3A and B). Since the overall activities of
full-length ERRs are combinations of their N-terminal AF-1s and
LBD-located AF-2s, the strong activating function of ERRc AF-1
may partially overcome the suppressive effect of kaempferol on
ERRc-LBD transcriptional activity, allowing ERRc to still functionas a constitutive transcription factor. This effect is more obvious
at lower concentrations like 5 lM at which kaempferol preferen-
tially activates ERb (Fig. 1B) while suppresses ERRa (Fig. 3A). At
higher concentrations like 20 lM, kaempferol additionally acti-
vates ERa (Fig. 1B) and suppresses ERRc (Fig. 3A). Since the doses
of kaempferol used in this study are still relatively high compared
to physiological concentrations [7], a more extensive investigation
using animal models would further shed lights on the importance
of kaempferol as an ERR inverse agonist in vivo.
ERRs play important roles in oxidative phosphorylation, mito-
chondrial biogenesis, and energy metabolism [20,21]. Additionally,
ERRa has been identiﬁed as prognostic markers in breast, prostate,
colon cancers [22]. Our observation that kaempferol functions as
an ERRa and ERRc inverse agonist and that higher level of ERRa
expression is positively related to adverse clinical outcome raises
an interesting possibility that kaempferol may exert its anti-cancer
activity at least in part through suppressing ERRa activity.Acknowledgements
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